¼¼°èÀÇ º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀå
Intra-abdominal Pressure Measurement Devices
»óǰÄÚµå : 1777368
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 357 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,228,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,684,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀåÀº 2030³â±îÁö 2¾ï 2,930¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1¾ï 5,200¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â º¹°­³»¾Ð ÃøÁ¤ ±â±â ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 7.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 2,930¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÏȸ¿ë Á¦Ç°Àº CAGR 8.4%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 5,350¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4,140¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR11.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀåÀº 2024³â¿¡ 4,140¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4,870¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.3%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.4%¿Í 6.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.7%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

º¹°­³»¾Ð ÃøÁ¤ ±â±â ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

º¹°­³»¾Ð(IAP) ÃøÁ¤ ±â±â ½ÃÀåÀº º¹°­³»¾ÐÁõÈıº(ACS), º¹°­³»¾ÐÇ×ÁøÁõ(IAH) ¹× Á¤È®ÇÑ ¾Ð·Â ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ÁßÁõ ȯÀÚ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ Å« ¸ð¸àÅÒÀ» ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ Àåºñ´Â ÁßȯÀÚ½Ç(ICU), ¼ö¼ú ȯ°æ, ¿Ü»ó °ü¸®¿¡ ÇʼöÀûÀ̸ç, ÀÓ»óÀǰ¡ Àå±â ±â´É ºÎÀü À§ÇèÀÌ Àִ ȯÀÚÀÇ º¹°­ ³» ¾Ð·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

IAP ¸ð´ÏÅ͸µÀº ÆÐÇ÷Áõ, ±Þ¼º ÃéÀå¿°, ±Þ¼º È­»ó, º¹ºÎ ¿Ü»ó, ¼ö¼ú ÈÄ ÇÕº´Áõ ȯÀÚ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. º¹°­ ³»¾ÐÀÌ ³ôÀº »óÅ·Π¹æÄ¡µÇ¸é Àå±âºÎÀü, Ç÷¿ªÇÐÀûÀÎ ºÒ¾ÈÁ¤¼º, »ç¸Á·ü Áõ°¡·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ Àü¿ë ÃøÁ¤ Àåºñ¸¦ ÀÌ¿ëÇÑ IAPÀÇ Á¶±â ¹ß°ß°ú Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ Áß¿ä½ÃµÇ°í ÀÖ½À´Ï´Ù.

ÀÚµ¿½Ä, Àúħ½À½Ä, Ä«Å×ÅÍ½Ä µî ¾Ð·Â ÃøÁ¤ ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÇ·áÁøÀº ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 ½Ç½Ã°£À¸·Î Á¤È®ÇÑ º¹°­ ³» ¾Ð·ÂÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¼¼°èº¹ºÎ±¸È¹ÁõÈıºÇÐȸ(WSACS)¿Í °°Àº ÁßȯÀÚ Ä¡·á ÇÐȸ°¡ Á¤ÇÑ °¡À̵å¶óÀΰú ÇÔ²² IAP ¸ð´ÏÅ͸µÀÇ ÀÓ»óÀû Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Àü ¼¼°è º´¿ø°ú ¿Ü»ó Ä¡·á ¼¾ÅÍ¿¡¼­ IAP ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä µ¿ÇâÀº?

IAP ÃøÁ¤ ½ÃÀåÀÇ °¡Àå µÎµå·¯Áø Æ®·»µå Áß Çϳª´Â ºñħ½ÀÀûÀ̰í ÀÚµ¿È­µÈ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ °³¹ßÀÔ´Ï´Ù. ±âÁ¸ÀÇ IAP ÃøÁ¤ ±â¼úÀº ¹æ±¤ ³»¾Ð Ä«Å×ÅÍ »ðÀÔ¼úÀÌ »ç¿ëµÇ¾ú´Âµ¥, ÀÌ´Â È¿°úÀûÀ̱ä ÇÏÁö¸¸ ¿ä·Î°¨¿°(UTI), Ä«Å×ÅÍ °ü·Ã °¨¿°, ½Ã¼ú·Î ÀÎÇÑ ºÒÆíÇÔ µîÀÇ À§Ç輺ÀÌ ÀÖ¾ú½À´Ï´Ù. ÀÌ¿¡ µû¶ó °¢ Á¦Á¶¾÷üµéÀº ħ½ÀÀûÀÎ Ä«Å×ÅÍ Ä¡·á°¡ ÇÊ¿ä ¾ø°í, Áö¼ÓÀûÀÎ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â ¼¾¼­ ±â¹Ý ¹× ¹«¼± IAP ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ½Ã½ºÅÛÀº °íÀ§Ç豺 ÁßȯÀÚ½Ç È¯ÀÚ³ª Àå±âÀûÀÎ ÁßÁõ ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â º¹°­ ³» ¾Ð·Â ¸ð´ÏÅ͸µÀ» ´ÙÁß ¸Å°³ º¯¼ö ÁßÁõ ȯÀÚ Ä¡·á ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ´Â °ÍÀÔ´Ï´Ù. ´ëºÎºÐÀÇ ÃֽŠICU´Â Ç÷¿ªÇÐ ÆÄ¶ó¹ÌÅÍ, Àå±â ±â´É ÁöÇ¥, º¹°­ ³»¾Ð µ¥ÀÌÅ͸¦ ´ÜÀÏ ÀÎÅÍÆäÀ̽º¿¡ ÅëÇÕÇÑ ÅëÇÕ ¸ð´ÏÅ͸µ Ç÷§ÆûÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °³¼±Çϰí, ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̸ç, IAP »ó½Â¿¡ µû¸¥ ÇÕº´ÁõÀ» °¨¼Ò½Ãŵ´Ï´Ù.

º´¿ø ³» °¨¿°(HAI) ¹× ±³Â÷ ¿À¿°ÀÇ À§Çè¿¡ ´ëÇÑ ¿ì·Á°¡ ³ô¾ÆÁö¸é¼­ ÀÏȸ¿ë ¹× ÀÏȸ¿ë IAP ÃøÁ¤ Ä«Å×ÅÍÀÇ Ã¤Åõµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ¾Ð·Â ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº °¨¿° ÀüÆÄ °¡´É¼ºÀ» ÁÙÀÌ°í ¾ö°ÝÇÑ ÀÇ·á °¨¿° Á¦¾î ÇÁ·ÎÅäÄÝÀ» ÁؼöÇÏ¿© ¾ö°ÝÇÑ ÀÇ·á °¨¿° Á¦¾î ÇÁ·ÎÅäÄÝÀ» ÁؼöÇÕ´Ï´Ù. ÀϺΠÁ¦Á¶¾÷ü´Â ȯÀÚÀÇ ¾ÈÀüÀ» À¯ÁöÇϸ鼭 Á¤È®ÇÑ ÃøÁ¤°ªÀ» º¸ÀåÇϱâ À§ÇØ ºñ¿ë È¿À²ÀûÀÌ°í ¸ê±Õ ¹× º¸Á¤µÈ ÀÏȸ¿ë IAP ¸ð´ÏÅ͸µ ŰƮ¸¦ Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ¼ö¼ú ¹× ¿Ü»ó ÇöÀå¿¡¼­ º¹°­ ³»¾Ð ¸ð´ÏÅ͸µÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âÁ¸ÀÇ ICU ¿ëµµ ¿Ü¿¡µµ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¿Ü°úÀÇ»ç¿Í ¸¶Ãë°ú ÀÇ»çµéÀº º¹ºÎ ±¸È¹ ÁõÈıº(ACS) ¹× ¼ö¼ú ÈÄ Àå±â ±â´É Àå¾Ö¿Í °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ ¼ö¼ú ÀüÈÄ È¯ÀÚ °ü¸®ÀÇ ÀÏȯÀ¸·Î IAP ÃøÁ¤À» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÇâÀº Á¤È®ÇÑ ¾Ð·Â ¸ð´ÏÅ͸µÀÌ È¯ÀÚÀÇ ¼º°øÀûÀÎ °á°ú¸¦ À§ÇØ ¸Å¿ì Áß¿äÇÑ ÁÖ¿ä º¹ºÎ ¼ö¼ú, ºñ¸¸ ¼ö¼ú, ÀÌ½Ä ¼ö¼ú¿¡¼­ ƯÈ÷ µÎµå·¯Áý´Ï´Ù.

º¹°­ ³»¾Ð ÃøÁ¤±â ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â À̽´´Â ¹«¾ùÀΰ¡?

º¹°­³»¾Ð ÃøÁ¤ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº º¸±ÞÀ» ¹æÇØÇÏ´Â ¸î °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä °úÁ¦ Áß Çϳª´Â ÀÇ·á Á¾»çÀÚµé »çÀÌ¿¡ Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄݰú ÀνÄÀÌ ºÎÁ·ÇÏ´Ù´Â °ÍÀÔ´Ï´Ù. IAP ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °¡À̵å¶óÀÎÀº Á¸ÀçÇÏÁö¸¸, ¸ðµç º´¿ø°ú ÁßȯÀÚ½ÇÀÌ º¹°­ ³»¾Ð Æò°¡¸¦ ÀÏ»óÀûÀΠȯÀÚ °ü¸®¿¡ ¿ÏÀüÈ÷ ÅëÇÕÇÑ °ÍÀº ¾Æ´Õ´Ï´Ù. ÀÌ·¯ÇÑ Ç¥ÁØÈ­ÀÇ ºÎÁ·Àº º¹°­³»¾ÐÇ×ÁøÁõ(IAH) ¹× º¹ºÎ ±¸È¹ ÁõÈıº(ACS)ÀÇ Áø´Ü Áö¿¬À¸·Î À̾îÁ® ȯÀÚÀÇ »ç¸Á·üÀ» ³ôÀÔ´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ °úÁ¦´Â °í±Þ IAP ¸ð´ÏÅ͸µ ÀåºñÀÇ ³ôÀº ºñ¿ëÀÔ´Ï´Ù. ÀÏȸ¿ë ÀÚµ¿È­µÈ ¾Ð·Â ÃøÁ¤ ¼Ö·ç¼ÇÀº ±âÁ¸ ¼öµ¿ Ä«Å×ÅÍ ¹æ½Ä¿¡ ºñÇØ °¡°ÝÀÌ ³ôÀº ¹Ý¸é, Á¤È®µµ Çâ»ó°ú °¨¿° Á¦¾î¸¦ Á¦°øÇÏ´Â ¹Ý¸é, ±âÁ¸ ¼öµ¿ Ä«Å×ÅÍ ¹æ½Ä¿¡ ºñÇØ °¡°ÝÀÌ ºñ½Ô´Ï´Ù. ¼Ò±Ô¸ð º´¿ø, ÀÚ¿øÀÌ ºÎÁ·ÇÑ ÀÇ·á½Ã¼³, °³¹ßµµ»ó±¹¿¡¼­´Â ¿¹»êÀÇ Á¦¾àÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Ã·´Ü ÀåºñÀÇ µµÀÔÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.

±âÁ¸ÀÇ Ä«Å×Å͸¦ ÀÌ¿ëÇÑ IAP ÃøÁ¤Àº ½Ã¼ú·Î ÀÎÇÑ ÇÕº´Áõ À§ÇèÀÌ ¿©ÀüÈ÷ ¿ì·ÁµÇ°í ÀÖ½À´Ï´Ù. ħ½ÀÀûÀÎ ¹æ±¤ ³»¾Ð ¸ð´ÏÅ͸µ ±â¼úÀº ÁßÁõ ȯÀÚ¿¡¼­ ¿ä·Î°¨¿°(UTI), Ä«Å×ÅÍ ¸·Èû, ºÒÆíÇÔÀÇ À§ÇèÀ» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÇØ°áÇϱâ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ¾ö°ÝÇÑ ¹«±Õ ÇÁ·ÎÅäÄÝ, ÀûÀýÇÑ ±³À° ¹× ÀýÂ÷»óÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇÑ °¨¿° °ü¸® Á¶Ä¡¸¦ öÀúÈ÷ ÁؼöÇØ¾ß ÇÕ´Ï´Ù.

¶ÇÇÑ, ±ÔÁ¦»óÀÇ ¹®Á¦³ª ÀÇ·á±â±â ±âÁØÀÇ Áؼö ¿©ºÎ°¡ »õ·Î¿î IAP ¸ð´ÏÅ͸µ ±â¼úÀÇ Á¦Ç° ½ÂÀΰú ½ÃÀå ÁøÀÔÀ» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA), À¯·´ÀǾàǰû(EMA), ±âŸ °¢±¹ÀÇ ÀÇ·á ±ÔÁ¦ ±â°ü µîÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â Á¦Ç° Ãâ½Ã Àü¿¡ ±â±âÀÇ Á¤È®¼º, ¾ÈÀü¼º, Áß¿ä °ü¸® ÇÁ·ÎÅäÄÝ Áؼö¸¦ ÀÔÁõÇÒ °ÍÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ºÎ´ãÀº Á¦Ç° °³¹ß ºñ¿ëÀ» Áõ°¡½ÃŰ°í ½ÃÀå È®´ë¸¦ Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù.

º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

º¹°­³»¾Ð ÃøÁ¤ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ÁßȯÀÚ½Ç ÀÔ¿ø Áõ°¡, º¹ºÎ ±¸È¹ ÁõÈıºÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿øµ¿·Â Áß Çϳª´Â ÆÐÇ÷Áõ, ¿Ü»ó, ¼ö¼ú ÈÄ ÇÕº´Áõ ¹ß»ý·ü Áõ°¡·Î Áö¼ÓÀûÀÎ IAP ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÁßȯÀÚ½Ç, ÀÀ±Þ½Ç, ¼ö¼ú½Ç ȯÀÚ´Â º¹°­³»¾ÐÇ×ÁøÁõ(IAH) ¹ß»ý À§ÇèÀÌ ³ôÀ¸¸ç, ¹æÄ¡ÇÒ °æ¿ì ´Ù¹ß¼º Àå±âºÎÀüÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

¼ö¼ú ÀüÈÄ ¹× ¼ö¼ú Ä¡·á¿¡¼­ º¹°­ ³» ¾Ð·Â ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ Å« ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. ¿Ü°úÀÇ»ç¿Í ¸¶Ãë°ú ÀÇ»çµéÀº º¹ºÎ Àç°Ç¼ú, Àå±â À̽Ä, ºñ¸¸ ¼ö¼ú°ú °°Àº °íÀ§Çè ¼ö¼ú¿¡¼­ IAP Æò°¡ÀÇ Á߿伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú Áß ¹× ¼ö¼ú ÈÄ º¹°­ ³» ¾Ð·Â »ó½ÂÀ» ¿¹¹æÇÔÀ¸·Î½á ÇÕº´ÁõÀ» ÁÙÀ̰í ÀÔ¿ø ±â°£À» ´ÜÃàÇϸç ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö Àֱ⠶§¹®¿¡ ½Ç½Ã°£ IAP ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼¾¼­¿Í ºñħ½ÀÀû ¸ð´ÏÅ͸µ ±â¼úÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹«¼± IAP ¼¾¼­, ½º¸¶Æ® Ä«Å×ÅÍ ½Ã½ºÅÛ, AI ±â¹Ý ¿¹Ãø ºÐ¼®°ú °°Àº Çõ½ÅÀ» ÅëÇØ ÀÇ·áÁøÀº ´õ ³ôÀº Á¤È®µµ¿Í ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 Áö¼ÓÀûÀÎ º¹°­ ³» ¾Ð·Â ¸ð´ÏÅ͸µÀ» ¼öÇàÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼Ç°ú ¿ø°Ý ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÁßÁõ ȯÀÚÀÇ Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ´Â ÈÞ´ë¿ë, »ç¿ëÇϱ⠽¬¿î IAP ÃøÁ¤ ÀåºñÀÇ °³¹ß¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÁßÁõ ȯÀÚ¸¦ À§ÇÑ ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚµµ ½ÃÀå ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸¹Àº º´¿ø, ¿Ü»ó¼¾ÅÍ, ÀÀ±Þ½Ç¿¡¼­´Â º¹°­ ³»¾Ð ÃøÁ¤À» Æ÷ÇÔÇÑ ´ÙÁß ¸Å°³º¯¼ö ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» ÅëÇÕÇϱâ À§ÇØ ÁßȯÀÚ ÀÇ·á±â±â¸¦ ¾÷±×·¹À̵åÇϰí ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï±¹ ½ÃÀåÀÇ ¼±ÁøÈ­µÈ ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ´ëÇÑ Áö¿ø Á¤Ã¥°ú ÀÚ±Ý Áö¿øÀº IAP ¸ð´ÏÅ͸µ ±â¼úÀÇ Áö¼ÓÀûÀΠäÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü, º¹°­³»¾ÐÁõ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÁßÁõ ÀÇ·á½Ã¼³ÀÇ È®´ë·Î º¹°­³»¾Ð ÃøÁ¤±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å, °æÁ¦¼º, ±ÔÁ¦ Áؼö¸¦ Áß½ÃÇÏ´Â Á¦Á¶¾÷ü´Â ÷´Ü ºñħ½ÀÀû ½Ç½Ã°£ IAP ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç°(ÀÏȸ¿ë, ±â±â);½Ã¼ú(±ÙÀ°, º¹ºÎ);¿ëµµ(º¹°­³»¾Ð, º¹ ³»¾Ð Ç×ÁøÁõ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø·Î ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Intra-abdominal Pressure Measurement Devices Market to Reach US$229.3 Million by 2030

The global market for Intra-abdominal Pressure Measurement Devices estimated at US$152.0 Million in the year 2024, is expected to reach US$229.3 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Disposables, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$153.5 Million by the end of the analysis period. Growth in the Equipment segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.4 Million While China is Forecast to Grow at 11.3% CAGR

The Intra-abdominal Pressure Measurement Devices market in the U.S. is estimated at US$41.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$48.7 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Intra-abdominal Pressure Measurement Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Intra-abdominal Pressure Measurement Devices Increasing?

The intra-abdominal pressure (IAP) measurement devices market is gaining significant momentum due to the rising incidence of abdominal compartment syndrome (ACS), intra-abdominal hypertension (IAH), and critical care conditions that require accurate pressure monitoring. These devices are essential for intensive care units (ICUs), surgical settings, and trauma management, helping clinicians assess intra-abdominal pressure in patients at risk of organ dysfunction.

IAP monitoring plays a crucial role in managing patients with sepsis, acute pancreatitis, major burns, abdominal trauma, and post-operative complications. High intra-abdominal pressure can lead to organ failure, hemodynamic instability, and increased mortality rates if left undetected. As a result, there is a growing emphasis on early detection and continuous monitoring of IAP using specialized measurement devices.

With technological advancements in pressure measurement systems, including automated, minimally invasive, and catheter-based devices, healthcare professionals can now obtain real-time and accurate intra-abdominal pressure readings with minimal patient discomfort. Additionally, increasing awareness about the clinical significance of IAP monitoring, along with guidelines established by critical care societies such as the World Society of Abdominal Compartment Syndrome (WSACS), has further driven adoption in hospitals and trauma care centers worldwide.

What Are the Key Trends Shaping the Intra-abdominal Pressure Measurement Devices Market?

One of the most prominent trends in the IAP measurement market is the development of non-invasive and automated monitoring systems. Traditional IAP measurement techniques involved bladder pressure catheterization, which, although effective, posed risks such as urinary tract infections (UTIs), catheter-associated infections, and procedural discomfort. In response, manufacturers are developing sensor-based and wireless IAP monitoring solutions that provide continuous, real-time data without the need for invasive catheterization. These advanced systems are particularly useful for high-risk ICU patients and long-term critical care monitoring.

Another significant trend is the integration of intra-abdominal pressure monitoring into multi-parameter critical care systems. Many modern ICUs are adopting integrated monitoring platforms that combine hemodynamic parameters, organ function indicators, and intra-abdominal pressure data into a single interface. This holistic approach to patient monitoring improves clinical decision-making, enhances patient safety, and reduces complications associated with elevated IAP.

The adoption of disposable and single-use IAP measurement catheters is also rising due to the growing concerns over hospital-acquired infections (HAIs) and cross-contamination risks. Disposable pressure monitoring systems reduce the likelihood of infection transmission and align with stringent healthcare infection control protocols. Several manufacturers are introducing cost-effective, sterile, and pre-calibrated disposable IAP monitoring kits to ensure accurate readings while maintaining patient safety.

In addition, the growing use of intra-abdominal pressure monitoring in surgical and trauma settings is expanding the market beyond traditional ICU applications. Surgeons and anesthesiologists are increasingly incorporating IAP measurement as part of perioperative and post-surgical patient management to prevent complications such as abdominal compartment syndrome (ACS) and post-operative organ dysfunction. This trend is particularly evident in major abdominal surgeries, bariatric procedures, and transplant surgeries, where precise pressure monitoring is crucial for successful patient outcomes.

What Challenges Are Impacting the Intra-abdominal Pressure Measurement Devices Market?

Despite the increasing demand for intra-abdominal pressure measurement devices, the market faces several challenges that could hinder widespread adoption. One of the primary challenges is the lack of standardized protocols and awareness among healthcare providers. While guidelines for IAP monitoring exist, not all hospitals and critical care units have fully integrated intra-abdominal pressure assessments into routine patient management. This lack of standardization can lead to delayed diagnosis of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS), increasing patient mortality rates.

Another significant challenge is the high cost of advanced IAP monitoring devices. While disposable and automated pressure measurement solutions offer improved accuracy and infection control, they also come at a higher price point compared to traditional manual catheterization techniques. Budget constraints in smaller hospitals, resource-limited healthcare facilities, and developing regions can limit the adoption of these advanced devices.

Risk of procedural complications remains a concern in traditional catheter-based IAP measurement. Invasive bladder pressure monitoring techniques can increase the risk of urinary tract infections (UTIs), catheter blockages, and discomfort in critically ill patients. To address this, healthcare providers must ensure strict aseptic protocols, proper training, and infection control measures to mitigate procedural risks.

Additionally, regulatory challenges and compliance with medical device standards can slow down product approvals and market entry for new IAP monitoring technologies. Stringent regulations by agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national healthcare regulatory bodies require manufacturers to demonstrate device accuracy, safety, and compliance with critical care protocols before commercialization. This regulatory burden can increase product development costs and delay market expansion.

What Factors Are Driving the Growth of the Intra-abdominal Pressure Measurement Devices Market?

The growth in the intra-abdominal pressure measurement devices market is driven by several factors, including increasing critical care admissions, the rising prevalence of abdominal compartment syndrome, and advancements in medical technology. One of the key drivers is the growing incidence of sepsis, major trauma, and post-surgical complications, which necessitate continuous IAP monitoring. Patients in ICUs, emergency departments, and post-operative care units are at high risk of developing intra-abdominal hypertension (IAH), which can lead to multiple organ failure if left untreated.

Another major growth driver is the increasing adoption of intra-abdominal pressure monitoring in perioperative and surgical care. Surgeons and anesthesiologists are recognizing the importance of IAP assessments in high-risk surgeries, such as abdominal reconstructions, organ transplants, and bariatric procedures. Preventing intra-abdominal hypertension during and after surgery reduces complications, shortens hospital stays, and improves patient outcomes, fueling demand for real-time IAP monitoring solutions.

The technological advancements in medical sensors and non-invasive monitoring techniques are further propelling market expansion. Innovations such as wireless IAP sensors, smart catheter systems, and AI-driven predictive analytics are enabling healthcare providers to perform continuous intra-abdominal pressure monitoring with greater accuracy and minimal patient discomfort. The increasing focus on digital healthcare solutions and remote monitoring is also contributing to the development of portable, easy-to-use IAP measurement devices that enhance accessibility for critically ill patients.

The rising healthcare expenditure and government investments in critical care infrastructure are also playing a crucial role in market growth. Many hospitals, trauma centers, and emergency departments are upgrading their critical care equipment to incorporate multi-parameter monitoring solutions, including intra-abdominal pressure measurement. Supportive policies and funding for advanced patient monitoring systems in developed and emerging healthcare markets are expected to drive continued adoption of IAP monitoring technologies.

With ongoing advancements in medical technology, increased awareness about intra-abdominal hypertension, and the expansion of critical care facilities, the intra-abdominal pressure measurement devices market is poised for sustained growth. Manufacturers that focus on innovation, affordability, and regulatory compliance will be well-positioned to capitalize on the growing demand for advanced, non-invasive, and real-time IAP monitoring solutions.

SCOPE OF STUDY:

The report analyzes the Intra-abdominal Pressure Measurement Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Disposables, Equipment); Procedure (Muscle, Abdomen); Application (Intra-compartment Pressure, Intra-abdominal Hypertension)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â